On our screens:Stocks with no debt
Is the price fair?
What MOH's price assumes
Today's price asks for 15% free cash flow growth a year; over the last three years Molina Healthcare, Inc. delivered −41%, the price is ahead of the record.
0.15
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 2.4%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- +15%
Growth the price implies · The price pays for +15% free cash flow growth a year for a decade; the business has delivered −41% a year over the last three.
- Price / book
- 1.67
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 1.67
- EV / EBIToperating margin 0.46%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 0.12
- Free cash flow, trailing twelve months
- $269M
- Market capitalisation
- $11.3B
- 3-year revenue growth
- +11%
- 3-year free cash flow growth
- −41%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $1.55 |
| Its own P/E history, median | $1.92 |
| Its own P/E history, upper quartile | $2.18 |
| 52-week range | $122.65 – $243.02 |
| Today | $196.42 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.